Elago, Theodora V.

HRN: 06-68-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
CEFTRIAXONE 1G (VIAL)
03/27/2024
04/03/2024
IV
2g
Q24h
Empiric
Checking Final Appropriateness 
03/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/27/2024
04/03/2024
IV
500mg
Q8
Empiric
Checking Final Appropriateness 
03/28/2024
CEFUROXIME 1.5GM (VIAL)
03/28/2024
04/04/2024
IV
1.5g
Q8
Empiric
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: